[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Smith & Nephew Plc (SN-.LN)

Smith & Nephew Plc (SN-.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Smith & Nephew Plc Hatters Lane Building 5, Croxley Park Watford Hertfordshire WD18 8YE GBR

https://www.smith-nephew.com P: 192-347-7100

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Key Statistics

Overview:

Market Capitalization, $K 9,420,141
Shares Outstanding, K 853,649
% of Insider Shareholders 0.29%
% of Institutional Shareholders 58.94%

Financials:

Annual Sales, $ 6,164 M
Annual Net Income, $ 625,000 K
Last Quarter Sales, $ 1,249 M
Last Quarter Net Income, $ 160,000 K

Growth:

1-Year Return 4.62%
3-Year Return -7.16%
5-Year Return -28.30%
5-Year Revenue Growth 6.21%
5-Year Earnings Growth 6.94%
5-Year Dividend Growth 0.23%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 0.72
EPS Growth vs. Prev Year -9.28%
Annual Dividend & Yield (Paid) 0.38 (2.62%)
Annual Dividend & Yield (Fwd) 0.48 (2.62%)
Most Recent Dividend 0.241 on 03/26/26
Next Ex-Dividends Date 03/26/26
Dividend Payable Date 05/27/26
Dividend Payout Ratio 52.72%
Most Recent Split 9-11 on 08/07/00

SN-.LN Ratios

Ratio
Price/Earnings ttm 20.83
Price/Earnings forward 13.62
Return-on-Equity % 11.84%
Return-on-Assets % 6.01%
Profit Margin % 10.14%
Debt/Equity 0.60
Price/Sales 2.11
Price/Book 2.40
Book Value/Share 4.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.